# ATF3 overexpression is associated with cardiac hypertrophy and electrical dysfunction accompanied by enhanced cardiac cell proliferation in zebrafish

**Authors:** Eunmi Kim, Jinho Kim, Hyun-Yi Moon, Ji Yeon Kim, Myong-Ho Jeong, Geun-Young Kim, Seung Hee Lee, Chul-Hong Kim, Jung-Woong Kim, Won-Ho Kim

PMC · DOI: 10.1038/s41598-025-33025-3 · Scientific Reports · 2025-12-26

## TL;DR

Overexpression of ATF3 in zebrafish hearts leads to heart enlargement and electrical issues, along with increased cell growth.

## Contribution

This study reveals novel insights into ATF3's role in cardiac hypertrophy and electrical dysfunction through a zebrafish model.

## Key findings

- ATF3 overexpression in zebrafish causes cardiac hypertrophy and fibrotic scarring.
- Transcriptome analysis shows downregulated apoptosis genes and upregulated proliferation genes in transgenic zebrafish hearts.
- Electrocardiogram measurements suggest electrical dysfunction resembling long QT syndrome in ATF3-expressing zebrafish.

## Abstract

Activating transcription factor 3 (ATF3) is a crucial regulator of gene expression in response to physiological stress across various tissues. Abnormal ATF3 expression is associated with cardiac dysfunction; however, the mechanisms by which it affects cardiac pathology remain unclear. In this study, we developed a cardiac-specific ATF3-expressing zebrafish line, Tg(myl7:ATF3), using a well-established vertebrate model for cardiovascular research to investigate the role of human ATF3 in the zebrafish heart. We conducted morphological assessments, immunofluorescence staining, electrocardiography, and transcriptome analysis on transgenic and wild-type zebrafish. Compared to wild-type siblings, Tg(myl7:ATF3) zebrafish exhibited significant pathophysiological changes, including cardiac hypertrophy and features resembling hypertrophic cardiomyopathy. Histological analysis revealed increased fibrotic scarring and disorganized sarcomeres. Electrocardiogram measurements indicated that ATF3 overexpression induced symptoms resembling long QT syndrome, suggesting electrical dysfunction. Transcriptome analysis demonstrated downregulation of apoptosis-related genes and upregulation of proliferation-related genes in the hearts of transgenic zebrafish. These findings suggest that ATF3 expression is associated with cardiac hypertrophy accompanied by increased proliferation of cardiac cells, including cardiomyocytes. The findings of this study provide novel insights into the role of ATF3 in cardiovascular disease progression.

The online version contains supplementary material available at 10.1038/s41598-025-33025-3.

## Linked entities

- **Genes:** ATF3 (activating transcription factor 3) [NCBI Gene 467], MYL7 (myosin light chain 7) [NCBI Gene 58498]
- **Diseases:** hypertrophic cardiomyopathy (MONDO:0005045), long QT syndrome (MONDO:0002442)
- **Species:** Danio rerio (taxon 7955)

## Full-text entities

- **Genes:** atf3 (activating transcription factor 3) [NCBI Gene 393939] {aka zgc:55526}, myl7 (myosin, light chain 7, regulatory) [NCBI Gene 30592] {aka cmlc2, mlc7, mylc2a, zgc:92755}
- **Diseases:** hypertrophic cardiomyopathy (MESH:D002312), cardiac hypertrophy (MESH:D006332), long QT syndrome (MESH:D008133), pathology (MESH:D005598), cardiac dysfunction (MESH:D006331), cardiovascular disease (MESH:D002318)
- **Species:** Homo sapiens (human, species) [taxon 9606], Danio rerio (leopard danio, species) [taxon 7955]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12830903/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12830903/full.md

---
Source: https://tomesphere.com/paper/PMC12830903